Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

JP Morgan and Rothschild & Co were top M&A financial advisers by value and volume in Middle East & Africa for Q1-Q3 2021, finds GlobalData

JP Morgan and Rothschild & Co were the top mergers and acquisition (M&A) financial advisers in the Middle East & Africa region for Q1-Q3 2021 by value and volume, respectively. JP Morgan advised on ten deals worth US$21.5bn, which was the highest value among all the advisers. Meanwhile, Rothschild & Co led in volume terms […]
Read more

Valneva’s COVID-19 vaccine will be strong competition for AstraZeneca and J&J, says GlobalData

Following the news that Valneva’s COVID-19 vaccine showed superior neutralizing antibody levels and an equal seroconversion rate and protection against SARS-CoV-2, compared to AstraZeneca’s Vaxzevria; Philipp Rosenbaum, PhD, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Valneva’s promising initial Phase III data, with at least equal protection levels and […]
Read more

COVID-19 brings mixed fortunes for commercial dose CMOs, says GlobalData

The contract manufacturing industry for finished dose pharmaceuticals had the lowest growth rate in a decade in 2020, according to GlobalData estimates. The leading data and analytics company reveals that total commercial dose contract manufacturing organization (CMO) contract revenue in 2020 grew by only 2.4% over 2019 revenue. Adam Bradbury, Pharma Analyst at GlobalData, comments: […]
Read more

Global surgical robotics market to hit $10.3bn by 2030, driven by new cloud computing, AI and robotics technologies, says GlobalData

Surgical robots are designed to solve the limitations currently present in minimally invasive surgeries, as well as to improve outcomes in open surgical procedures. According to GlobalData, a leading data and analytics company, the global surgical robotics market was worth $4.6bn in 2020 and is forecast to reach $10.3bn by 2030, at a strong compound annual growth rate (CAGR) of 8.5%. This growth rate will be driven by the development of new medical device products that utilise the latest innovations in […]
Read more

Chips shortage for autos likely to last into 2022, says GlobalData

Following the news from Daimler that a shortage of critical semiconductor components hit deliveries in the first quarter and will further impact sales in the second quarter; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “Daimler’s warnings today are the latest in a long line of warnings and […]
Read more
,

Discussion on subscriptions by automotive companies rose by 73% in 2020 as they look to diversify sales channels, finds GlobalData

Consumers’ need for greater convenience and flexibility, and the shift away from the need to own assets, is driving auto companies to try and capitalize by pursuing subscription models. While auto companies have discussed subscriptions in the past, discussions in earnings transcripts surged in 2020, with the entry of more original equipment manufacturers (OEMs) in […]
Read more

Blackrock’s sustainability discussions rose in 2021, with focus on slashing anti-green investment, finds GlobalData

As sustainability discussions are gaining traction across various sectors, Blackrock turned its focus towards green investments in Q1 2021. GlobalData’s Filing Analytics platform identified that Blackrock’s mentions of sustainability already rose by around 22% in 2021* compared to 2020. While earnings transcript discussions around sustainability rose by around five times in 2020 for companies on […]
Read more

Cleary Gottlieb Steen & Hamilton, Kirkland & Ellis top M&A legal advisers by value, volume in financial services sector for Q1 2021, finds GlobalData

Cleary Gottlieb Steen & Hamilton and Kirkland & Ellis emerged as the top mergers and acquisitions (M&A) legal advisers in the financial services for Q1 2021 by value and volume, respectively. Cleary Gottlieb Steen & Hamilton advised on four deals worth US$23.8bn, the highest value among all the advisers. Meanwhile, Kirkland & Ellis led in […]
Read more

Gemtesa is a welcome entrant to US overactive bladder market as it addresses need for safer therapies, says GlobalData

The commercial launch of Urovant Sciences’ first product, Gemtesa (vibegron), a beta 3 adrenergic receptor agonist in the US, addresses overactive bladder (OAB) symptoms by increasing bladder capacity and an unmet need for alternative, safer therapies for US patients, says GlobalData, a leading data and analytics company. In recent years, Urovant has become established as […]
Read more
1 … 33 34 35 36 37 … 93